Diagnostic Solutions for Human Infectious Diseases

AMPLIRUN® INFLUENZA RNA CONTROL

Purified RNA of influenza to be used to control in vitro diagnosis techniques based in nucleic acids amplification.

Purified complete microbial genome
Any sequence can be amplified
Concentration range: 12.500-20.000 copies/µl determined by qPCR
Can be used in any molecular testing platform
Non infectious
Lyophilized presentation
A resuspension vial is provided within the kit with Molecular Biology Grade Water

> Further information available for the design of primers and probes:
· Partial sequences:
- Influenza A H1: PP825741, PP825742, PP825743, PP825744,
PP825745, PP825746, PP825747,PP825748

- Influenza A H3: : PP815005, PP815006, PP815007, PP815008 , PP815009 PP815010 PP815011 PP815012
- Influenza A H5: GQ454868.1, GQ454867.1, GQ454866.1, GQ454865.1, GQ454864.1,
GQ454863.1, GQ454862.1, GQ454861.1
- Influenza B: PP815638 , PP815639, PP815640, PP815641, PP815642, PP815643, PP815644 , PP815645
- Novel Influenza: OR565313 , OR565314 , OR565315 , OR565316 , OR565317 , OR565318 , OR565319 , OR565320 , OR565321

References

General information

Product

Reference

Nº Test

Class

Product AMPLIRUN® INFLUENZA A H1 RNA CONTROL

Reference

MBC028

Nº Test -

Product AMPLIRUN® INFLUENZA A H3 RNA CONTROL

Reference

MBC029

Nº Test -

Product AMPLIRUN® INFLUENZA A H5 RNA CONTROL

Reference

MBC052

Nº Test -

Product AMPLIRUN® INFLUENZA B RNA CONTROL

Reference

MBC030

Nº Test -

Product AMPLIRUN® NOVEL INFLUENZA A H1N1 RNA CONTROL

Reference

MBC082

Nº Test -

Product

Reference

Nº Test

Class

Product AMPLIRUN® INFLUENZA A H1 RNA CONTROL

Reference

MBC028

Nº Test -

Product AMPLIRUN® INFLUENZA A H3 RNA CONTROL

Reference

MBC029

Nº Test -

Product AMPLIRUN® INFLUENZA A H5 RNA CONTROL

Reference

MBC052

Nº Test -

Product AMPLIRUN® INFLUENZA B RNA CONTROL

Reference

MBC030

Nº Test -

Product AMPLIRUN® NOVEL INFLUENZA A H1N1 RNA CONTROL

Reference

MBC082

Nº Test -

Ensure accuracy and reproducibility of your molecular tests for infectious diseases with Vircell’s quantified PCR controls.

Take advantage of its wide use:

Amplification of the genotype of interest
Validation of in-house and commercial methods (sensitivity, specificity, limit of detection, precision)
Absolute sample quantification by standard curve
Objective interpretation of results
Overcome limitations of using clinical samples as positive controls

Lyophilized presentation improves stability and avoids extra transport costs as there is no need of dry ice. Controls must be reconstituted with 50 µl of Molecular Biology Grade Water, free of DNase, RNase.